India to double drug inspectors to boost oversight

MUMBAI Wed May 21, 2014 7:08pm IST

Pictures of Hindu gods hang beside a medicines rack inside a clinic in Pune August 27, 2012. REUTERS/Danish Siddiqui/Files

Pictures of Hindu gods hang beside a medicines rack inside a clinic in Pune August 27, 2012.

Credit: Reuters/Danish Siddiqui/Files

Related Topics

MUMBAI (Reuters) - India will spend 30 billion rupees ($511 million) and double the number of drug inspectors in the next three years to meet global manufacturing standards, the country's health regulator said on Wednesday.

A rash of import bans imposed by the U.S. Food and Drug Administration on leading Indian generic drugmakers due to lapses in production processes over the past year has triggered concerns about the quality of drugs sold in other markets, including in India.

The government will increase the number of inspectors at the Central Drugs Standard Control Organization (CDSCO) to 1,000 from 500 now, Drugs Controller General of India G.N. Singh said in a statement on Wednesday.

The number of officials at state regulatory departments will be raised to 3,000 from 800 now, he said.

"India's reference system (for drug testing and intellectual property) will be at par with the top world standards in two to three years and will even match theĀ U.S. in three to five years," Singh said.

In India, states regulate the manufacture and distribution of drugs, while CDSCO, which is the federal authority, handles approvals of new drugs and clinical trials, oversees drug imports and coordinates the activities of state regulators.

A chronic shortage of inspectors has made it difficult for regulators to monitor the more than 10,000 drug manufacturing factories in India, which supply to more than 200 countries.

Multiple state drug regulators told Reuters in April that skeletal staff and lack of enough drug testing laboratories had rendered their departments unequipped to carry out their duties.

($1 = 58.7600 Indian Rupees)

(Reporting by Zeba Siddiqui in Mumbai; Editing by Prateek Chatterjee)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Xi's South Asia Visit

REUTERS SHOWCASE

Economic Pulse

Economic Pulse

Weak industry and stubborn inflation hinder India's economic recovery.  Full Article 

Lipitor Lawsuit

Lipitor Lawsuit

Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor.  Full Article 

Losing Glitter

Losing Glitter

India's love affair with gold may be over, as prices slide.  Full Article 

Factory Data

Factory Data

China Aug factory output growth near six-year low.  Full Article 

New Ford Models

New Ford Models

Ford to launch four new car models in India over 18-20 months.  Full Article 

Sales Forecast

Sales Forecast

Honda India two-wheeler unit sees FY15 sales rising more than a fifth.  Full Article 

Dispute Resolved

Dispute Resolved

Airbus gets Qatar A380 okay, but questions on A320 test.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage